An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program.

Gonçalo Forjaz Jill S Barnholtz-Sloan Carol KruchkoRebecca SiegelSerban NegoitaQuinn T OstromLois DickieJennifer RuhlAlison L Van Dyke Nirav PatilGino CioffiKimberly D MillerKristin WaiteAngela B Mariotto

Published in: Neuro-oncology advances (2020)

Declining trends observed in our study may be attributable to recent changes in diagnostic classification and the coding practices stemming from those changes. The recode used in this study enables histology reporting to reflect the changes. It also provides a first step toward the reporting of malignant and nonmalignant brain and other CNS tumors in the Surveillance, Epidemiology, and End Results (SEER) Program by clinically relevant histology groupings.

Keyphrases

public health
healthcare
quality improvement
machine learning
primary care
white matter
risk factors
resting state
deep learning
emergency department
blood brain barrier
adverse drug